Human medicines European public assessment report (EPAR): Prometax, rivastigmine, Alzheimer Disease;Parkinson Disease;Dementia, Date of authorisation: 03/12/1998, Revision: 46, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.